Dein persönlicher KI-Karriere-Agent
Medical Director(m/w/x)
Medical leadership for Phase 3 trial unblinding and data readout in immunology therapies. MD with 3-5+ years late-stage biotech/pharma experience and Phase 3 trial involvement required. Stock option program participation, Wellpass, OpenUp.
Anforderungen
- Medical Degree (MD), ideally with neurology training/clinical background, or advanced science/related degree
- 3-5+ years experience in biotech/pharma or academic clinical research (late-stage trials)
- Previous involvement in Phase 3 clinical trials
- Expertise in Multiple Sclerosis, advantageous scientific understanding of disease mechanisms/clinical development pathways
- Solid knowledge of GCP and international regulatory requirements (FDA, EMA)
- Experience in assessing risks/opportunities/implications in late-stage drug development
- Ability to lead and collaborate in cross-functional/matrix teams
- Excellent communication skills and strategic mindset
- Native-level English proficiency
Aufgaben
- Lead unblinding, data review, and readout of Phase 3 trials
- Analyze and interpret comprehensive trial data
- Provide medical leadership for Clinical Study Reports
- Support pre-NDA regulatory activities (FDA, EMA)
- Communicate clinical outcomes and study rationale clearly
- Collaborate with medical advisory board and key investigators
- Represent the program at scientific and medical conferences
- Collaborate with NDA preparation team
- Shape key messages, clinical summaries, and data presentations for NDA
- Evaluate high-level Phase 3 results
- Support global registration and reimbursement strategies
- Support scientific publications
- Provide hands-on medical monitoring for Phase 3 trials
- Review activities during data cleaning
- Partner with Pharmacovigilance on medical assessment of safety cases
- Review and prepare narratives for serious adverse events (SAEs)
- Lead interactions with regulatory authorities
- Ensure alignment on clinical evidence and program strategy
Berufserfahrung
- 3 - 5 Jahre
Ausbildung
- Bachelor-AbschlussODER
- Master-Abschluss
Sprachen
- Englisch – fließend
Benefits
Karriere- und Weiterentwicklung
- Professional growth opportunities
Startup-Atmosphäre
- Dynamic, flexible, and innovative working environment
Attraktive Vergütung
- Stock option program participation
Gesundheits- & Fitnessangebote
- Wellpass
Mentale Gesundheitsförderung
- OpenUp
Noch nicht perfekt?
- Immunic AGVollzeitnur vor OrtSeniorGräfelfing
- Alexion
Medical Science Liaison Manager, Neurology(m/w/x)
Vollzeitnur vor OrtSeniorMünchen - Scholar Rock
Country Medical Director(m/w/x)
Vollzeitnur vor OrtSeniorFrankfurt am Main, München - BioNTech SE
(Senior-) Director Clinical Development(m/w/x)
Vollzeitnur vor OrtSeniorMainz, München - Regeneron GmbH
Country Medical Director(m/w/x)
Vollzeitnur vor OrtManagementMünchen
Medical Director(m/w/x)
Medical leadership for Phase 3 trial unblinding and data readout in immunology therapies. MD with 3-5+ years late-stage biotech/pharma experience and Phase 3 trial involvement required. Stock option program participation, Wellpass, OpenUp.
Anforderungen
- Medical Degree (MD), ideally with neurology training/clinical background, or advanced science/related degree
- 3-5+ years experience in biotech/pharma or academic clinical research (late-stage trials)
- Previous involvement in Phase 3 clinical trials
- Expertise in Multiple Sclerosis, advantageous scientific understanding of disease mechanisms/clinical development pathways
- Solid knowledge of GCP and international regulatory requirements (FDA, EMA)
- Experience in assessing risks/opportunities/implications in late-stage drug development
- Ability to lead and collaborate in cross-functional/matrix teams
- Excellent communication skills and strategic mindset
- Native-level English proficiency
Aufgaben
- Lead unblinding, data review, and readout of Phase 3 trials
- Analyze and interpret comprehensive trial data
- Provide medical leadership for Clinical Study Reports
- Support pre-NDA regulatory activities (FDA, EMA)
- Communicate clinical outcomes and study rationale clearly
- Collaborate with medical advisory board and key investigators
- Represent the program at scientific and medical conferences
- Collaborate with NDA preparation team
- Shape key messages, clinical summaries, and data presentations for NDA
- Evaluate high-level Phase 3 results
- Support global registration and reimbursement strategies
- Support scientific publications
- Provide hands-on medical monitoring for Phase 3 trials
- Review activities during data cleaning
- Partner with Pharmacovigilance on medical assessment of safety cases
- Review and prepare narratives for serious adverse events (SAEs)
- Lead interactions with regulatory authorities
- Ensure alignment on clinical evidence and program strategy
Berufserfahrung
- 3 - 5 Jahre
Ausbildung
- Bachelor-AbschlussODER
- Master-Abschluss
Sprachen
- Englisch – fließend
Benefits
Karriere- und Weiterentwicklung
- Professional growth opportunities
Startup-Atmosphäre
- Dynamic, flexible, and innovative working environment
Attraktive Vergütung
- Stock option program participation
Gesundheits- & Fitnessangebote
- Wellpass
Mentale Gesundheitsförderung
- OpenUp
Über das Unternehmen
Immunic AG
Branche
Pharmaceuticals
Beschreibung
Immunic Therapeutics is a biotechnology company developing immunology therapies for chronic inflammatory and autoimmune diseases.
Noch nicht perfekt?
- Immunic AG
Senior Medical Director(m/w/x)
Vollzeitnur vor OrtSeniorGräfelfing - Alexion
Medical Science Liaison Manager, Neurology(m/w/x)
Vollzeitnur vor OrtSeniorMünchen - Scholar Rock
Country Medical Director(m/w/x)
Vollzeitnur vor OrtSeniorFrankfurt am Main, München - BioNTech SE
(Senior-) Director Clinical Development(m/w/x)
Vollzeitnur vor OrtSeniorMainz, München - Regeneron GmbH
Country Medical Director(m/w/x)
Vollzeitnur vor OrtManagementMünchen